“I felt like I was being attacked by this invisible enemy,” Witt says. “It was nothing that I asked for, and I didn’t even know how to battle it.” So he channeled his frustration into music and art that depicted his pain. It was “a way I could express myself,” he says. “It was liberating.”

Quick Read

“There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales,” a researcher said

Quick Read

“I asked him to bring me a gun, and he wanted to know why,” Mr. Cowart later told an interviewer. “I told him, ‘Can’t you see I’m a dead man? I’m going to die anyway, I’ve got to put myself out of this misery.’ He said, in a very caring way, ‘I can’t do that.’ It was the first of many times that Mr. Cowart, who was 25 then, would beg to be allowed to die.”

Quick Read

“Buprenorphine patients remain disproportionately white and, while whites are more likely to have opioid addiction, the difference in prevalence alone is unlikely to explain this gap,” commented our Brendan Saloner

Quick Read

A panel of government-appointed experts in Germany agreed unanimously that the human germline “is not inviolable,” rejecting one objection to using genome editing technologies such as CRISPR to make heritable changes in the DNA of human embryos, sperm, or eggs

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

How prepared is the Trump administration for an influx of unaccompanied minors at the border? A new complaint shows shelters in New Jersey were already failing to respond when kids got hurt or sick

Quick Read